Literature DB >> 15187376

High prevalence of enterohemorrhagic Escherichia coli (EHEC) O157 from cattle in selected regions of Japan.

Ayako Ezawa1, Fumie Gocho, Koji Kawata, Tatsufumi Takahashi, Naoya Kikuchi.   

Abstract

The prevalence of enterohemorrhagic Escherichia coli (EHEC) O157 was examined in bovine faeces. EHEC O157 was isolated from the faeces of 42 (13.0%) of 324 cattle. Of the 4 farms and the facilities tested, the 3 farms and the facilities were found positive for EHEC O157. The highest isolation rate among the farms was 33.7%. The prevalence of EHEC O157 in heifers was higher than that in calves and other cattle. No cattle positive for EHEC O157 showed any clinical signs except 2 calves with diarrhea in a veterinary hospital. Almost all isolates possessed the stx gene, and Stx-positive strains carrying both stx(1) and stx(2) genes were predominant. These results indicate that EHEC O157 are distributed in bovine faeces, and that dairy and beef farms in selected regions of Japan are heavily contaminated with the organisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187376     DOI: 10.1292/jvms.66.585

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

Review 1.  Escherichia coli O157:H7: animal reservoir and sources of human infection.

Authors:  Witold A Ferens; Carolyn J Hovde
Journal:  Foodborne Pathog Dis       Date:  2010-11-30       Impact factor: 3.171

2.  Dynamics of Escherichia coli Virulence Factors in Dairy Herds and Farm Environments in a Longitudinal Study in the United States.

Authors:  Elisabetta Lambertini; Jeffrey S Karns; Jo Ann S Van Kessel; Huilin Cao; Ynte H Schukken; David R Wolfgang; Julia M Smith; Abani K Pradhan
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

3.  Comparative study on the epidemiological aspects of enterohemorrhagic Escherichia coli infections between Korea and Japan, 2006 to 2010.

Authors:  Won-Chang Lee; Young Hwan Kwon
Journal:  Korean J Intern Med       Date:  2016-05       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.